PPARG and metabolic dysfunction-associated steatotic liver disease: Meanwhile, the NAFLD+CM group showed recovery of the normal PPAR-γ protein levels in the hepatic and extrahepatic tissues leading to decreased steatosis and improved blood lipid profile.